Jasmonates are plant lipidederived oxylipins that act as key signaling compounds in plant immunity, germination, and development. Although some physiological activities of natural jasmonates in mammalian cells have been investigated, their anti-inflammatory actions in mammalian cells remain unclear. Here, we investigated whether jasmonates protect mouse microglial MG5 cells against lipopolysaccharide (LPS)einduced inflammation. Among the jasmonates tested, only 12-oxo-phytodienoic acid (OPDA) suppressed LPS-induced expression of the typical inflammatory cytokines interleukin-6 and tumor necrosis factor a. In addition, only OPDA reduced LPS-induced nitric oxide production through a decrease in the level of inducible nitric oxide synthase. Further mechanistic studies showed that OPDA suppressed neuroinflammation by inhibiting nuclear factor kB and p38 mitogen-activated protein kinase signaling in LPS-activated MG5 cells. In addition, OPDA induced expression of suppressor of cytokine signaling-1 (SOCS-1), a negative regulator of inflammation, in MG5 cells. Finally, we found that the nuclear factor erythroid 2-related factor 2 signaling cascade induced by OPDA is not involved in the antiinflammatory effects of OPDA. These results demonstrate that OPDA inhibited LPS-induced cell inflammation in mouse microglial cells via multiple pathways, including suppression of nuclear factor kB, inhibition of p38, and activation of SOCS-1 signaling.
Introduction
Jasmonates are plant-derived oxylipins similar to mammalian oxylipins such as prostaglandins and leukotrienes [1] . Jasmonates are present universally in plants but not in animal systems and are found in relatively high amounts in fruits and vegetables [2, 3] . In plants, jasmonates such as 12-oxo-phytodienoic acid (OPDA), jasmonic acid (JA), methyl jasmonate (MeJA), jasmonoyl isoleucine (JA-Ile), and 12-hydroxy-jasmonic acid (12-OH-JA) are ubiquitously occurring signaling molecules that function as important regulators of plant immunity, germination, and development [4e6] . Although physiological functions of jasmonates in plant cells have been extensively studied, studies on their action for mammalian cells are still limited. The anti-cancer properties of MeJA and the anti-oxidative effects of OPDA have been reported in mammalian cells [7, 8] . Some synthetic jasmonate analogs are also reported to have anti-inflammatory activity in mammalian macrophages [9] . However, little is known about the effects of natural jasmonates against inflammation in microglia.
In mammals, microglia are the resident innate immune cells in the brain that play a major role in host defense and tissue repair in the central nerve system [10] . They become overactive in response to environmental stress and exposure to stimuli such as lipopolysaccharides (LPS) [10] . Overactivated microglia release proinflammatory and neurotoxic factorsdincluding interleukin 6 (IL-6), tumor necrosis factor a (TNF-a), and nitric oxide (NO)dthat are involved in various neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, cerebral ischemia, and multiple sclerosis [10, 11] . Therefore, regulating the inflammatory molecules released by abnormally activated microglia may provide a means for treatment of neuroinflammatory diseases.
Nuclear factor kB (NF-kB) is an important transcription factor involved in regulating the expression of various genes related to inflammatory responses [12] . NF-kB normally exists in the cytoplasm by binding inhibitory subunit of NF-kB a (IkBa). Once activated by stimulants such as LPS, IkB kinase (IKK) phosphorylates IkBa, leading to its proteasomal degradation. IkBa degradation releases and activates NF-kB, which is translocated from the cytosol to the nucleus, where it binds specific promoter regions of target genes and induces transcription of pro-inflammatory and neurotoxic mediators such as IL-6, TNF-a, and inducible nitric oxide synthase (iNOS) [12, 13] .
Mitogen-activated protein kinases (MAPKs), including p38, JNK, and ERK, are a family of serine/threonine protein kinases that regulate inflammatory and immune responses involved in LPSinduced gene expression [14] . Increased MAPK activity is a critical regulator of pro-inflammatory and neurotoxic factors in neurodegenerative processes [14, 15] . Proteins of the suppressor of cytokine signaling (SOCS) family are endogenous negative regulators of cytokine signaling and pro-inflammatory cytokine expression [16] . SOCS can suppress cytokine signaling in vitro and in vivo [16, 17] , and thus the SOCS family is considered an important regulator of normal immune physiology and immune disease.
Nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that regulates transcription of phase II and other enzymes that reduce oxidative stress, inhibits inflammatory responses in the brain [18] . Furthermore, one of its target genes, heme oxygenase 1 (HO-1), suppresses LPS-induced inflammation [18] . We previously reported that OPDA induced Nrf2 activation and subsequent expression of antioxidants and phase II detoxification enzymes involving HO-1 [8] . We also showed that OPDA suppressed oxidative stresseinduced cell death via the Nrf2 pathway in human neurons [8] . Chronic inflammation and oxidative stress in microglia and neurons have been implicated in various neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis [10, 11, 19] . Thus, compounds that have both antioxidative and anti-inflammatory effects may be attractive for therapy.
The effects of natural jasmonates against inflammation in microglia cells are unclear. We therefore investigated the antiinflammatory effects of jasmonates and the mechanism of their activities against LPS-induced pro-inflammatory responses in mouse microglial MG5 cells. We show that, among jasmonates, only OPDA inhibited inflammatory responses by suppressing the NF-kB and p38 MAPK pathways and by activating SOCS-1 signaling, each of which was independent of the Nrf2 pathway. Taken together our results indicate that OPDA may be useful for the treatment of neurodegenerative diseases.
Materials and methods

Materials
Dulbecco's modified Eagle medium (DMEM) and Lipofectamine RNAiMAX were obtained from Life Technologies. Fetal bovine serum was obtained from Cell Culture Bioscience. cis-OPDA, (±)-JA, and (±)-MeJA were obtained from Cayman Chemical. (À)-JA-Ile and (±)-12-OH-JA were purchased from OlchemIm. Antibodies against Nrf2, lamin, HO-1, and b-actin were obtained from Santa Cruz Biotechnology, Biomol, and Abcam, respectively. Antiephospho p65, anti-p65, anti-IkBa, anti-phospho JNK, anti-JNK, anti-phospho p38, and anti-p38 were obtained from Cell Signaling. Horseradish peroxidaseeconjugated secondary antibodies were from GE Healthcare. NE-PER Nuclear and Cytoplasmic Extraction Reagent and the Micro BCA Protein Assay kit were from Pierce. Chemi-Lumi One Super was obtained from Nacalai. LPS, protease inhibitor cocktail, and phosphatase inhibitor cocktail were purchased from Sigma. All Stars Negative Control siRNA was obtained from Qiagen.
The Maxwell 16 RNA purification kit was from Promega. ReverTra Ace and PVDF Blocking Reagent for Can Get Signal were from Toyobo. The nitric oxide assay kit, Mouse IL-6 Quantikine ELISA kit, and Mouse TNF-a Quantikine ELISA kit were purchased from R&D Systems.
Cell culture
Mouse microglial MG5 cells (JCRB Cell Bank, catalog number: IFO50520) were grown in DMEM with 10% fetal bovine serum and A1 (IFO50519)econditioned medium. Cells were maintained at 37 C in a humidified atmosphere with 5% CO 2 . Cells were plated at the appropriate density and treated with various jasmonate concentrations (7.5, 15, and 30 mM) for various times (6 and 24 h).
Control cells were treated with medium lacking jasmonates. For LPS treatment, cells were pretreated with each of several jasmonates for 24 h, the medium was replaced with fresh medium without jasmonates, and the cells were exposed to 1 mg/mL LPS for various times (30 min, 3 h, and 24 h). Control cells were treated with medium without jasmonates or LPS.
Immunoblotting
Cells were solubilized using NE-PER Nuclear and Cytoplasmic Extraction Reagent or RIPA buffer with 1% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail for nuclear protein extraction or whole-cell protein extraction, respectively. Protein concentrations were determined using the Micro BCA Protein Assay kit. Proteins were subjected to SDS-PAGE and subsequently transferred to a polyvinylidene difluoride membrane. The membranes were blocked with PVDF Blocking Reagent for Can Get Signal and incubated overnight at 4 C with primary antibodies against Nrf2, lamin, HO-1, phospho p65, p65, IkBa, phospho JNK, JNK, phospho p38, p38, or b-actin. Each membrane was washed in phosphatebuffered saline containing 0.1% (v/v) Tween-20 and incubated for 1 h at room temperature with horseradish peroxidaseeconjugated secondary antibody. Chemiluminescent signals generated by Chemi-Lumi One Super reagent were detected with the Image Quant LAS 3000 CCD camera system (Fujifilm).
Quantitative real-time PCR analysis
Total RNA was extracted using the Maxwell RNA purification system, which includes a DNase step, and then cDNA was synthesized using random hexamer primers and ReverTra Ace reverse transcriptase. Quantitative real-time PCR was performed using the 7500HT Fast Real-Time PCR system (Applied Biosystems). TaqMan Gene Expression Assay kits for IL-6 (Mm00446190), TNF-a (Mm00443260), iNOS (Mm00440502), and SOCS-1 (Mm00782550) were used. Data were normalized to GAPDH mRNA, which was amplified and detected using the following primers and probes (5 0 e3 0 ): forward primer, CAAATTCAACGGCA-CAGTCAAG; reverse primer, CCTCACCCCATTTGATGTTAGTG; probe (FAM-TAMRA), CCATCACCATCTTCCAGGAGCGAGAC.
Measurement of cytokines and NO
Levels of cytokines in culture supernatants were measured using Quantikine ELISA kits according to manufacturer's instructions. Generation of NO was determined by measuring accumulation of nitrite (a stable end product of NO) in the medium using a nitric oxide assay kit.
Nrf2 knockdown by siRNA transfection
MG5 cells were transiently transfected with Nrf2 siRNA (5 0 -AACTCTCAAGTTAATTTCTTA-3 0 ) or All Stars Negative Control siRNA using Lipofectamine RNAiMAX.
Results
OPDA decreases LPS-induced inflammatory responses
We first examined the effects of OPDA, JA, MeJA, JA-Ile, and 12-OH-JA on LPS-induced inflammatory activation in mouse microglial MG5 cells. Cells were pretreated with jasmonates for 24 h and exposed to LPS for an additional 3 h ( Fig. 1) . LPS treatment significantly increased mRNA expression of the pro-inflammatory cytokines IL-6 and TNF-a, as well as iNOS, which produces NO. Pretreatment with OPDA significantly reduced LPS-induced mRNA expression of IL-6, TNF-a, and iNOS in a concentration-dependent manner (Fig. 1) . No other jasmonate showed any antiinflammatory effect. These results indicated that, among jasmonates, OPDA has unique properties that protect MG5 cells against inflammation induced by LPS.
In a parallel experiment, we analyzed the effects of OPDA on IL-6, TNF-a, and NO production following LPS treatment. Cells were pretreated with OPDA for 24 h and exposed to LPS for an additional 24 h (Fig. 2) . IL-6 and TNF-a protein and NO levels were significantly increased in the culture medium of control LPSstimulated MG5 cells. However, pretreatment with OPDA resulted in a significant decrease in all three levels in a concentrationdependent manner (Fig. 2) . These results suggested that OPDA is effective in suppressing production of pro-inflammatory and neurotoxic mediators in activated microglia by altering transcription of genes encoding IL-6, TNF-a, and iNOS.
OPDA suppresses LPS-induced activation of NF-kB and p38 MAPK and induces SOCS-1 transcription
NF-kB, a heterodimer of p65 and p50, is the most important transcription factor involved in the regulation of pro-inflammatory and neurotoxic mediators, including IL-6, TNF-a, and iNOS, in activated microglial cells. Therefore, we investigated whether OPDA is involved in NF-kB signaling pathway. A critical early step in NF-kB activation is the degradation of the inhibitory protein IkBa. As shown in Fig. 3A , IkBa was markedly degraded at 30 min after LPS treatment, but this LPS-induced IkBa degradation was suppressed by OPDA. Phosphorylation of p65 is also important for enhanced NF-kB-mediated transactivation. We observed that OPDA also suppressed LPS-induced phosphorylation of p65 (Fig. 3A) . These findings indicated that OPDA suppresses IL-6, TNF-a, and iNOS expression at least in part through an NF-kB-dependent mechanism.
To investigate other mechanisms responsible for the inhibitory Fig. 1 . OPDA decreases LPS-induced IL-6, TNF-a, and iNOS mRNA expression. MG5 cells were pretreated with 7.5, 15, or 30 mM OPDA or 30 mM JA, MeJA, JA-Ile, or 12-OH-JA for 24 h. After the medium was changed, cells were exposed to 1 mg/mL effects of OPDA on inflammation, we examined the effects of OPDA on MAPK signaling. It is well known that LPS-mediated stimulation of the pro-inflammatory reaction in immune cells involves activation of MAPK signaling pathways. Cells were pretreated with OPDA for 24 h and then stimulated with LPS for 30 min. The phosphorylation of p38 and JNK was increased by LPS stimulation. OPDA reduced LPS-induced phosphorylation of p38, but had no effect on phosphorylation of JNK (Fig. 3B) . These results indicated that the suppressed phosphorylation of p38 may contribute to the inhibitory effect of OPDA on LPS-induced pro-inflammatory responses in MG5 cells. The SOCS family represents an important endogenous negative regulatory mechanism of cytokine signaling that also affects proinflammatory cytokine expression. We investigated whether OPDA altered mRNA expression of SOCS-1 in MG5 cells. After 24 h treatment with OPDA, the level of SOCS-1 transcript was significantly elevated (Fig. 3C ), suggesting that SOCS-1 may mediate the anti-inflammatory action of OPDA.
The Nrf2 pathway is activated by OPDA but is not involved in OPDA-mediated anti-inflammatory responses
Because Nrf2 signaling regulates cellular anti-inflammatory responses, we examined whether OPDA protects cells from LPSinduced inflammation by activating Nrf2 signaling pathway. First, we examined the effect of OPDA on the intracellular localization of Nrf2 in MG5 cells. We found that OPDA treatment increased expression of Nrf2 protein in nuclear extracts (Fig. 4A ). Furthermore, after treatment with OPDA, we observed elevated expression of HO-1 protein, encoded by one of the target genes for Nrf2 (Fig. 4B) .
To investigate whether Nrf2 signaling contributes to the suppressive effects of OPDA on LPS-induced inflammation, we transiently transfected MG5 cells with Nrf2 siRNA and evaluated protein levels for Nrf2 and HO-1, as well as LPS-induced mRNA expression for IL-6, TNF-a, and iNOS. Nrf2 siRNA reduced the OPDAinduced nuclear translocation of Nrf2 and upregulation of HO-1 (Fig. 4A, B ). However, OPDA-induced anti-inflammatory responses against LPS were not suppressed by Nrf2 knockdown (Fig. 4C) . These data suggested that Nrf2 activation and the subsequent upregulation of Nrf2 target genes are not involved in the antiinflammatory properties of OPDA.
Discussion
Neuroinflammation and oxidative stress are critical components in the pathogenesis of neurodegenerative diseases [10] . Under these pathological conditions, microglia become activated, inducing the release of various pro-inflammatory and neurotoxic mediators that are involved in the response to neuronal injury [10, 20] . In this regard, the inhibition of a variety of proinflammatory and neurotoxic factors may provide an effective therapeutic approach against neuroinflammatory diseases.
TNF-a and IL-6 are produced by activated microglia and play a central role in initiating and regulating the cytokine cascade during brain inflammation [21] . Here, we showed that OPDA inhibited the production of these cytokines following LPS-activated inflammation in microglial MG5 cells. In the brain, NO is mainly produced by microglia through activation of iNOS, and accumulation of NO is toxic to neurons as oxidative stress [22] . In this study, we demonstrated that OPDA prevents NO production in LPS-activated microglia by inhibiting iNOS expression.
Next, we investigated the mechanism of the anti-inflammatory effects of OPDA. We demonstrated that OPDA suppressed LPS- Fig. 2 . OPDA attenuates LPS-induced production of IL-6, TNF-a, and NO. MG5 cells were pretreated with 7.5, 15, or 30 mM OPDA for 24 h. After the medium was changed, cells were exposed to 1 mg/mL LPS for 24 h. IL-6 (A), TNF-a (B) and NO (C) levels in the medium were determined. All data were normalized to OPDA-untreated, LPS-stimulated cells (100%).
Values indicate mean ± S.E.M. from three separate experiments. ##p < 0.01 versus unstimulated control; *p < 0.05 and **p < 0.01 versus LPS alone. activated NF-kB signaling. Activation of NF-kB requires phosphorylation of IkBa by IKK, which results in targeted degradation of IkBa and subsequent induction of NF-kB-regulated expression of inflammatory and neurotoxic genes such as IL-6, TNFa, and iNOS [12, 13] . The structure of OPDA is similar to that of 15-deoxy-D-12,14prostaglandin J 2 (15d-PGJ 2 ), a mammalian prostaglandin that has a cyclopentenone ring with an electrophilic carbon that can react covalently by the Michael addition reaction with cysteine residues in cellular proteins [23] . 15d-PGJ 2 directly inhibits NF-kB-dependent gene expression through covalent modification of critical cysteine residues in IKK and the DNA-binding domains of NF-kB subunits [23] . The mechanism by which OPDA inhibits NF-kB signaling might be similar to that of 15d-PGJ 2 , i.e., owing to their structural similarity. This is consistent with the finding that none of the other jasmonates, which are not electrophiles, could repress NF-kB-dependent gene expression. In addition, the non-natural MeJA analog methyl 4,5-dehydrojasmonate, which contains a cyclopentenone ring, inhibits production of IL-6, TNF-a, and NO in LPS-activated macrophages [9] . Thus, the cyclopentenone ring may be important for the observed anti-inflammatory effects.
We showed that OPDA suppressed LPS-activated p38 but not JNK. MAP kinases play a crucial role in controlling signaling events that contribute to the production of neuroinflammatory mediators [14] . In particular, the p38 MAPK has been strongly linked to neuroinflammation. Microglia from p38-deficient mice have a diminished cytokine response to LPS [24] . In addition, the p38 inhibitor decreases production of pro-inflammatory cytokines in the brain and attenuates neuronal damage in the neurodegenerative mouse model [25] . Although the mechanism is unknown, the inhibition of p38 by OPDA would be important for anti-inflammation in MG5 cells.
Macrophages from SOCS-1-deficient mice are hypersensitive to LPS signaling, resulting in overproduction of TNF-a and IL-6 [17] . Furthermore, overexpression of SOCS-1 inhibits LPS-induced IL-6 secretion by blocking JAK-STAT activation in macrophages [26] . Thus, induction of SOCS-1 expression by OPDA treatment may be related to anti-inflammatory effects.
15d-PGJ 2 , which is structurally similar to OPDA, inhibits the production of inflammatory mediators and cytokines in activated microglia [27] . In addition, 15d-PGJ 2 suppresses p38 activity and induces SOCS-1 expression in microglia [28, 29] . Moreover, 15-PGJ 2 attenuates microglial inflammation and shows protective effects in animal models of neuroinflammatory diseases such as brain ischemia, multiple sclerosis, and spinal cord injury [30, 31] . Given the similar chemical structures and physiological activities of 15-PGJ 2 and OPDA, it is possible that OPDA will be effective for treatment of neuroinflammatory diseases.
Our study demonstrates that OPDA inhibits production of LPSinduced inflammatory mediators and cytokines via multiple pathways, including inhibition of NF-kB and p38 and activation of SOCS-1 signaling, in microglial MG5 cells. OPDA also activated the Nrf2 pathway in microglial MG5 cells. Although, the contribution of Nrf2 activation to anti-inflammatory effects in microglia was small, we previously reported that OPDA rescued neuronal cells from oxidative stresseinduced death by increasing cellular antioxidative defense via activation of the Nrf2 pathway [8] . In neurodegenerative diseases, activated microglia can damage neurons by producing pro-inflammatory factors involving TNF-a and oxidative stress stimuli such as NO. The microglia would then become activated in response to factors released from damaged neurons, inducing toxicity in neighboring neurons and resulting in a self-amplifying cycle of inflammation/oxidative stressemediated neurodegeneration [10, 11, 19] . Therefore, OPDA, which has both antiinflammatory and antioxidative effects, may be a possible therapeutic compound for treatment of inflammatory-and oxidative stresserelated diseases, including neurodegenerative disorders.
